Identifying metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus using clinic-based prediction tools

BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a global cause of chronic liver disease. The prevalence of MASLD is high in patients with type 2 diabetes mellitus (T2DM). Various non-invasive tools such as th...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Juma Alkaabi, Bachar Afandi, Omar Alhaj, Darakhshan Kanwal, Adnan Agha
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-09-01
Subjects:	metabolic dysfunction-associated steatotic liver disease diabetes mellitus Hamaguchi criteria NAFLD fibrosis score fibrosis-4 index
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1425145/full